3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.

doi:10.1128/JVI.72.6.4858-4865.1998

Back to search

Article

3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.

Journal of virology - 1 Jun 1998

Arts E J, Quiñones-Mateu M E, Albright J L, Marois J P, Hough C, Gu Z, Wainberg M A

Abstract excerpt

Difficulties in deciphering the mechanisms of 3'-azido-3'-deoxythymidine (AZT)-resistance by human immunodeficiency virus type 1 (HIV-1) variants are due in part to an inability to reconstitute resistance in vitro using AZT-resistant reverse transcriptases. We decided to characterize mechanisms o...

Topics

Anti-HIV Agents
Drug Resistance, Microbial
Genome, Viral
HIV-1
Humans
Jurkat Cells
Mutation
Zidovudine

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.